NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Kemper AR, Coeytaux R, Sanders GD, et al. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. (Comparative Effectiveness Reviews, No. 28.)
This publication is provided for historical reference only and the information may be out of date.
Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet].
Show detailsTimothy Beukelman, M.D., M.S.C.E.
University of Alabama at Birmingham
Birmingham, AL
Patti Forest, M.D., M.B.A.
North Carolina Division of Medical Assistance
North Carolina Department of Health and Human Services
Raleigh, NC
Hilary M. Haftel, M.D., M.H.P.E.
University of Michigan Medical School
Ann Arbor, MI
Norman T. Ilowite, M.D.
Children's Hospital at Montefiore and Albert Einstein College of Medicine
Bronx, NY
Elizabeth Mellins, M.D.
Stanford School of Medicine
Stanford, CA
C. Egla Rabinovich, M.D., M.P.H.
Duke University Medical Center
Durham, NC
Carole A. Wallace, M.D.
University of Washington and Seattle Children's Hospital
Seattle, WA
- Technical Expert Panel - Disease-Modifying Antirheumatic Drugs (DMARDs) in Child...Technical Expert Panel - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA)
- shibire, isoform J [Drosophila melanogaster]shibire, isoform J [Drosophila melanogaster]gi|281360946|ref|NP_001162766.1|Protein
- uS12 prolyl 3-hydroxylase [Caenorhabditis elegans]uS12 prolyl 3-hydroxylase [Caenorhabditis elegans]gi|17531931|ref|NP_495088.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...